Synjardy
- Product NDC
- 0597-0159
- Requested package NDC
- 0597-0159-66
- 11-digit product format
- 005970159
- Labeler code
- 0597
- Product ID
- 0597-0159_06cb5e7a-ca7a-474a-a968-b3ddc7af1c43
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- empagliflozin and metformin hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Application
- NDA206111
- Marketing category
- NDA
- Marketing start
- 2015-08-26
- Substance
- EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
- Active strength
- 5; 500 mg/1; mg/1
- Pharmacologic classes
- Biguanide [EPC], Biguanides [CS], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 0597-0159 | 0597-0159-66 | D | Discontinued by firm | 2026-08-03 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N206111-001 | SYNJARDY | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | 5MG;500MG | TABLET / ORAL | RLD | 2015-08-26 | |
| N206111-002 | SYNJARDY | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | 5MG;1GM | TABLET / ORAL | RLD | 2015-08-26 | |
| N206111-003 | SYNJARDY | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | 12.5MG;500MG | TABLET / ORAL | RLD | 2015-08-26 | |
| N206111-004 | SYNJARDY | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | 12.5MG;1GM | TABLET / ORAL | RLD, RS | 2015-08-26 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N206111-001 | 7713938 | 2027-04-15 | Drug substance, Drug product | 2015-09-30 | |
| N206111-001 | 7713938*PED | 2027-10-15 | Pediatric extension | ||
| N206111-001 | 7579449 | 2028-08-01 | Drug substance | 2015-09-30 | |
| N206111-001 | 7579449*PED | 2029-02-01 | Pediatric extension | ||
| N206111-001 | 12115179 | 2030-02-11 | U-4023 | 2024-11-12 | |
| N206111-001 | 12115179*PED | 2030-08-11 | Pediatric extension | ||
| N206111-001 | 10610489 | 2030-09-30 | Drug product | 2020-05-01 | |
| N206111-001 | 10610489*PED | 2031-03-30 | Pediatric extension | ||
| N206111-001 | 12527810 | 2033-04-22 | U-4403 | 2026-02-10 | |
| N206111-001 | 12527810*PED | 2033-10-22 | Pediatric extension | ||
| N206111-001 | 10258637 | 2034-04-03 | U-2290 | 2019-04-30 | |
| N206111-001 | 11090323 | 2034-04-03 | U-3193 | 2021-08-20 | |
| N206111-001 | 11666590 | 2034-04-03 | U-4154 | 2025-03-28 | |
| N206111-001 | 11813275 | 2034-04-03 | U-3759 | 2023-12-13 | |
| N206111-001 | 11833166 | 2034-04-03 | U-3776 | 2024-01-03 | |
| N206111-001 | 11833166 | 2034-04-03 | U-3777 | 2024-01-03 | |
| N206111-001 | 12263153 | 2034-04-03 | U-4154 | 2025-04-29 | |
| N206111-001 | 12427162 | 2034-04-03 | U-4287 | 2025-10-29 | |
| N206111-001 | 12433906 | 2034-04-03 | U-4293 | 2025-10-29 | |
| N206111-001 | 12433906 | 2034-04-03 | U-4294 | 2025-10-29 | |
| N206111-001 | 12433906 | 2034-04-03 | U-4295 | 2025-10-29 | |
| N206111-001 | 12433906 | 2034-04-03 | U-4296 | 2025-10-29 | |
| N206111-001 | 12433906 | 2034-04-03 | U-4304 | 2025-10-29 | |
| N206111-001 | 9949997 | 2034-05-17 | U-3532 | 2023-03-01 | |
| N206111-001 | 9949997 | 2034-05-17 | U-3533 | 2023-03-01 | |
| N206111-001 | 10258637*PED | 2034-10-03 | Pediatric extension | ||
| N206111-001 | 11090323*PED | 2034-10-03 | Pediatric extension | ||
| N206111-001 | 11813275*PED | 2034-10-03 | Pediatric extension | ||
| N206111-001 | 11833166*PED | 2034-10-03 | Pediatric extension | ||
| N206111-001 | 12433906*PED | 2034-10-03 | Pediatric extension | ||
| N206111-001 | 9949997*PED | 2034-11-17 | Pediatric extension | ||
| N206111-002 | 7713938 | 2027-04-15 | Drug substance, Drug product | 2015-09-30 | |
| N206111-002 | 7713938*PED | 2027-10-15 | Pediatric extension | ||
| N206111-002 | 7579449 | 2028-08-01 | Drug substance | 2015-09-30 | |
| N206111-002 | 7579449*PED | 2029-02-01 | Pediatric extension | ||
| N206111-002 | 12115179 | 2030-02-11 | U-4023 | 2024-11-12 | |
| N206111-002 | 12115179*PED | 2030-08-11 | Pediatric extension | ||
| N206111-002 | 10610489 | 2030-09-30 | Drug product | 2020-05-01 | |
| N206111-002 | 10610489*PED | 2031-03-30 | Pediatric extension | ||
| N206111-002 | 12527810 | 2033-04-22 | U-4403 | 2026-02-10 | |
| N206111-002 | 12527810*PED | 2033-10-22 | Pediatric extension | ||
| N206111-002 | 10258637 | 2034-04-03 | U-2290 | 2019-04-30 | |
| N206111-002 | 11090323 | 2034-04-03 | U-3193 | 2021-08-20 | |
| N206111-002 | 11666590 | 2034-04-03 | U-4154 | 2025-03-28 | |
| N206111-002 | 11813275 | 2034-04-03 | U-3759 | 2023-12-13 | |
| N206111-002 | 11833166 | 2034-04-03 | U-3776 | 2024-01-03 | |
| N206111-002 | 11833166 | 2034-04-03 | U-3777 | 2024-01-03 | |
| N206111-002 | 12263153 | 2034-04-03 | U-4154 | 2025-04-29 | |
| N206111-002 | 12427162 | 2034-04-03 | U-4287 | 2025-10-29 | |
| N206111-002 | 12433906 | 2034-04-03 | U-4293 | 2025-10-29 | |
| N206111-002 | 12433906 | 2034-04-03 | U-4294 | 2025-10-29 | |
| N206111-002 | 12433906 | 2034-04-03 | U-4295 | 2025-10-29 | |
| N206111-002 | 12433906 | 2034-04-03 | U-4296 | 2025-10-29 | |
| N206111-002 | 12433906 | 2034-04-03 | U-4304 | 2025-10-29 | |
| N206111-002 | 9949997 | 2034-05-17 | U-3532 | 2023-03-01 | |
| N206111-002 | 9949997 | 2034-05-17 | U-3533 | 2023-03-01 | |
| N206111-002 | 10258637*PED | 2034-10-03 | Pediatric extension | ||
| N206111-002 | 11090323*PED | 2034-10-03 | Pediatric extension | ||
| N206111-002 | 11813275*PED | 2034-10-03 | Pediatric extension | ||
| N206111-002 | 11833166*PED | 2034-10-03 | Pediatric extension | ||
| N206111-002 | 12433906*PED | 2034-10-03 | Pediatric extension | ||
| N206111-002 | 9949997*PED | 2034-11-17 | Pediatric extension | ||
| N206111-003 | 7713938 | 2027-04-15 | Drug substance, Drug product | 2015-09-30 | |
| N206111-003 | 7713938*PED | 2027-10-15 | Pediatric extension | ||
| N206111-003 | 7579449 | 2028-08-01 | Drug substance | 2015-09-30 | |
| N206111-003 | 7579449*PED | 2029-02-01 | Pediatric extension | ||
| N206111-003 | 12115179 | 2030-02-11 | U-4023 | 2024-11-12 | |
| N206111-003 | 12115179*PED | 2030-08-11 | Pediatric extension | ||
| N206111-003 | 10610489 | 2030-09-30 | Drug product | 2020-05-01 | |
| N206111-003 | 10610489*PED | 2031-03-30 | Pediatric extension | ||
| N206111-003 | 12527810 | 2033-04-22 | U-4403 | 2026-02-10 | |
| N206111-003 | 12527810*PED | 2033-10-22 | Pediatric extension | ||
| N206111-003 | 10258637 | 2034-04-03 | U-2290 | 2019-04-30 | |
| N206111-003 | 11090323 | 2034-04-03 | U-3193 | 2021-08-20 | |
| N206111-003 | 11666590 | 2034-04-03 | U-4154 | 2025-03-28 | |
| N206111-003 | 11833166 | 2034-04-03 | U-3776 | 2024-01-03 | |
| N206111-003 | 11833166 | 2034-04-03 | U-3777 | 2024-01-03 | |
| N206111-003 | 12263153 | 2034-04-03 | U-4154 | 2025-04-29 | |
| N206111-003 | 12427162 | 2034-04-03 | U-4287 | 2025-10-29 | |
| N206111-003 | 12433906 | 2034-04-03 | U-4293 | 2025-10-29 |
Orange Book exclusivity#
| Application-product | Exclusivity code | Expiration |
|---|---|---|
| N206111-001 | NPP | 2026-06-20 |
| N206111-001 | PED | 2026-12-20 |
| N206111-002 | NPP | 2026-06-20 |
| N206111-002 | PED | 2026-12-20 |
| N206111-003 | NPP | 2026-06-20 |
| N206111-003 | PED | 2026-12-20 |
| N206111-004 | NPP | 2026-06-20 |
| N206111-004 | PED | 2026-12-20 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N206111-001 | SYNJARDY | 5MG;500MG | TABLET / ORAL | RLD | 2015-08-26 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206111-002 | SYNJARDY | 5MG;1GM | TABLET / ORAL | RLD | 2015-08-26 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206111-003 | SYNJARDY | 12.5MG;500MG | TABLET / ORAL | RLD | 2015-08-26 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206111-004 | SYNJARDY | 12.5MG;1GM | TABLET / ORAL | RLD, RS | 2015-08-26 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N206111-001 | SYNJARDY | 5MG;500MG | TABLET / ORAL | RLD | 2015-08-26 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N206111-002 | SYNJARDY | 5MG;1GM | TABLET / ORAL | RLD | 2015-08-26 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N206111-003 | SYNJARDY | 12.5MG;500MG | TABLET / ORAL | RLD | 2015-08-26 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N206111-004 | SYNJARDY | 12.5MG;1GM | TABLET / ORAL | RLD, RS | 2015-08-26 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N206111-001 | SYNJARDY | 5MG;500MG | TABLET / ORAL | RLD | 2015-08-26 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N206111-002 | SYNJARDY | 5MG;1GM | TABLET / ORAL | RLD | 2015-08-26 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N206111-003 | SYNJARDY | 12.5MG;500MG | TABLET / ORAL | RLD | 2015-08-26 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N206111-004 | SYNJARDY | 12.5MG;1GM | TABLET / ORAL | RLD, RS | 2015-08-26 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N206111-001 | SYNJARDY | 5MG;500MG | TABLET / ORAL | RLD | 2015-08-26 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N206111-002 | SYNJARDY | 5MG;1GM | TABLET / ORAL | RLD | 2015-08-26 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N206111-003 | SYNJARDY | 12.5MG;500MG | TABLET / ORAL | RLD | 2015-08-26 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N206111-004 | SYNJARDY | 12.5MG;1GM | TABLET / ORAL | RLD, RS | 2015-08-26 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N206111-001 | SYNJARDY | 5MG;500MG | TABLET / ORAL | RLD | 2015-08-26 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N206111-002 | SYNJARDY | 5MG;1GM | TABLET / ORAL | RLD | 2015-08-26 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N206111-003 | SYNJARDY | 12.5MG;500MG | TABLET / ORAL | RLD | 2015-08-26 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N206111-004 | SYNJARDY | 12.5MG;1GM | TABLET / ORAL | RLD, RS | 2015-08-26 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N206111-001 | SYNJARDY | 5MG;500MG | TABLET / ORAL | RLD | 2015-08-26 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N206111-002 | SYNJARDY | 5MG;1GM | TABLET / ORAL | RLD | 2015-08-26 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N206111-003 | SYNJARDY | 12.5MG;500MG | TABLET / ORAL | RLD | 2015-08-26 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N206111-004 | SYNJARDY | 12.5MG;1GM | TABLET / ORAL | RLD, RS | 2015-08-26 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N206111-001 | SYNJARDY | 5MG;500MG | TABLET / ORAL | RLD | 2015-08-26 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N206111-002 | SYNJARDY | 5MG;1GM | TABLET / ORAL | RLD | 2015-08-26 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N206111-003 | SYNJARDY | 12.5MG;500MG | TABLET / ORAL | RLD | 2015-08-26 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N206111-004 | SYNJARDY | 12.5MG;1GM | TABLET / ORAL | RLD, RS | 2015-08-26 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N206111-001 | SYNJARDY | 5MG;500MG | TABLET / ORAL | RLD | 2015-08-26 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N206111-002 | SYNJARDY | 5MG;1GM | TABLET / ORAL | RLD | 2015-08-26 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N206111-003 | SYNJARDY | 12.5MG;500MG | TABLET / ORAL | RLD | 2015-08-26 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N206111-004 | SYNJARDY | 12.5MG;1GM | TABLET / ORAL | RLD, RS | 2015-08-26 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N206111-001 | SYNJARDY | 5MG;500MG | TABLET / ORAL | RLD | 2015-08-26 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N206111-002 | SYNJARDY | 5MG;1GM | TABLET / ORAL | RLD | 2015-08-26 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N206111-003 | SYNJARDY | 12.5MG;500MG | TABLET / ORAL | RLD | 2015-08-26 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N206111-004 | SYNJARDY | 12.5MG;1GM | TABLET / ORAL | RLD, RS | 2015-08-26 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N206111-001 | SYNJARDY | 5MG;500MG | TABLET / ORAL | RLD | 2015-08-26 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N206111-002 | SYNJARDY | 5MG;1GM | TABLET / ORAL | RLD | 2015-08-26 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N206111-003 | SYNJARDY | 12.5MG;500MG | TABLET / ORAL | RLD | 2015-08-26 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N206111-004 | SYNJARDY | 12.5MG;1GM | TABLET / ORAL | RLD, RS | 2015-08-26 | d06236e962d9… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N206111-001 | AB | 1 | 3a93d1ddd44b… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N206111-002 | AB | 1 | 3a93d1ddd44b… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N206111-003 | AB | 1 | 3a93d1ddd44b… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N206111-004 | AB | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | N206111-001 | AB | 1 | f41ea6bd6efb… |
| 2022-10-28 04:53 UTC | 2022-10 | N206111-002 | AB | 1 | f41ea6bd6efb… |
| 2022-10-28 04:53 UTC | 2022-10 | N206111-003 | AB | 1 | f41ea6bd6efb… |
| 2022-10-28 04:53 UTC | 2022-10 | N206111-004 | AB | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | N206111-001 | AB | 1 | e64feba35796… |
| 2022-09-29 23:25 UTC | 2022-09 | N206111-002 | AB | 1 | e64feba35796… |
| 2022-09-29 23:25 UTC | 2022-09 | N206111-003 | AB | 1 | e64feba35796… |
| 2022-09-29 23:25 UTC | 2022-09 | N206111-004 | AB | 1 | e64feba35796… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N206111-001 | 7713938 | 2027-04-15 | Drug substance, Drug product | 2015-09-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206111-001 | 7713938*PED | 2027-10-15 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N206111-001 | 7579449 | 2028-08-01 | Drug substance | 2015-09-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206111-001 | 7579449*PED | 2029-02-01 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N206111-001 | 12115179 | 2030-02-11 | U-4023 | 2024-11-12 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206111-001 | 12115179*PED | 2030-08-11 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N206111-001 | 10610489 | 2030-09-30 | Drug product | 2020-05-01 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206111-001 | 10610489*PED | 2031-03-30 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N206111-001 | 10258637 | 2034-04-03 | U-2290 | 2019-04-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206111-001 | 11090323 | 2034-04-03 | U-3193 | 2021-08-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206111-001 | 11666590 | 2034-04-03 | U-4154 | 2025-03-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206111-001 | 11813275 | 2034-04-03 | U-3759 | 2023-12-13 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206111-001 | 11833166 | 2034-04-03 | U-3776 | 2024-01-03 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206111-001 | 11833166 | 2034-04-03 | U-3777 | 2024-01-03 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206111-001 | 12263153 | 2034-04-03 | U-4154 | 2025-04-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206111-001 | 12427162 | 2034-04-03 | U-4287 | 2025-10-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206111-001 | 12433906 | 2034-04-03 | U-4304 | 2025-10-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206111-001 | 12433906 | 2034-04-03 | U-4293 | 2025-10-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206111-001 | 12433906 | 2034-04-03 | U-4294 | 2025-10-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206111-001 | 12433906 | 2034-04-03 | U-4295 | 2025-10-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206111-001 | 12433906 | 2034-04-03 | U-4296 | 2025-10-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206111-001 | 9949997 | 2034-05-17 | U-3532 | 2023-03-01 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206111-001 | 9949997 | 2034-05-17 | U-3533 | 2023-03-01 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206111-001 | 10258637*PED | 2034-10-03 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N206111-001 | 11090323*PED | 2034-10-03 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N206111-001 | 11813275*PED | 2034-10-03 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N206111-001 | 11833166*PED | 2034-10-03 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N206111-001 | 12433906*PED | 2034-10-03 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N206111-001 | 9949997*PED | 2034-11-17 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N206111-002 | 7713938 | 2027-04-15 | Drug substance, Drug product | 2015-09-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206111-002 | 7713938*PED | 2027-10-15 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N206111-002 | 7579449 | 2028-08-01 | Drug substance | 2015-09-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206111-002 | 7579449*PED | 2029-02-01 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N206111-002 | 12115179 | 2030-02-11 | U-4023 | 2024-11-12 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206111-002 | 12115179*PED | 2030-08-11 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N206111-002 | 10610489 | 2030-09-30 | Drug product | 2020-05-01 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206111-002 | 10610489*PED | 2031-03-30 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N206111-002 | 10258637 | 2034-04-03 | U-2290 | 2019-04-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206111-002 | 11090323 | 2034-04-03 | U-3193 | 2021-08-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206111-002 | 11666590 | 2034-04-03 | U-4154 | 2025-03-28 | 011fe1cb6892… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N206111-001 | NPP | 2026-06-20 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N206111-001 | PED | 2026-12-20 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N206111-002 | NPP | 2026-06-20 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N206111-002 | PED | 2026-12-20 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N206111-003 | NPP | 2026-06-20 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N206111-003 | PED | 2026-12-20 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N206111-004 | NPP | 2026-06-20 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N206111-004 | PED | 2026-12-20 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N206111-001 | NPP | 2026-06-20 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N206111-001 | PED | 2026-12-20 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N206111-002 | NPP | 2026-06-20 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N206111-002 | PED | 2026-12-20 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N206111-003 | NPP | 2026-06-20 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N206111-003 | PED | 2026-12-20 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N206111-004 | NPP | 2026-06-20 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N206111-004 | PED | 2026-12-20 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N206111-001 | NPP | 2026-06-20 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N206111-001 | PED | 2026-12-20 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N206111-002 | NPP | 2026-06-20 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N206111-002 | PED | 2026-12-20 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N206111-003 | NPP | 2026-06-20 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N206111-003 | PED | 2026-12-20 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N206111-004 | NPP | 2026-06-20 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N206111-004 | PED | 2026-12-20 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N206111-001 | NPP | 2026-06-20 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N206111-001 | PED | 2026-12-20 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N206111-002 | NPP | 2026-06-20 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N206111-002 | PED | 2026-12-20 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N206111-003 | NPP | 2026-06-20 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N206111-003 | PED | 2026-12-20 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N206111-004 | NPP | 2026-06-20 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N206111-004 | PED | 2026-12-20 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N206111-001 | NPP | 2026-06-20 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N206111-001 | PED | 2026-12-20 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N206111-002 | NPP | 2026-06-20 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N206111-002 | PED | 2026-12-20 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N206111-003 | NPP | 2026-06-20 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N206111-003 | PED | 2026-12-20 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N206111-004 | NPP | 2026-06-20 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N206111-004 | PED | 2026-12-20 | b8a1b40f171c… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Synjardy | EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Boehringer Ingelheim Pharmaceuticals, Inc. | 0fdd0255-0055-65f3-b2c0-db8fbb87beae | 2026-01-30 | Boxed warning, Warnings, Adverse reactions | 206111 NDA206111 0597-0159-66 0597-0159 00597015966 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Synjardy
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| EMPAGLIFLOZIN | 5 mg/1 |
| METFORMIN HYDROCHLORIDE | 500 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| HDC1R2M35U | Internal UNII lookup |
| 786Z46389E | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1664315 | Internal RxNorm lookup |
| 1664321 | Internal RxNorm lookup |
| 1664323 | Internal RxNorm lookup |
| 1664325 | Internal RxNorm lookup |
| 1664326 | Internal RxNorm lookup |
| 1664328 | Internal RxNorm lookup |
| 1665367 | Internal RxNorm lookup |
| 1665369 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 0fdd0255-0055-65f3-b2c0-db8fbb87beae | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0597-0159-18 | Synjardy | 180 in 1 BOTTLE | TABLET | 180 | 22 | |
| 0597-0159-60 | Synjardy | 60 in 1 BOTTLE | TABLET | 60 | 22 | |
| 0597-0159-66 | Synjardy | 1 in 1 CARTON | TABLET | 1 | 22 | |
| 0597-0159-66 | Synjardy | 14 in 1 BOTTLE | TABLET | 14 | 22 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0597-0159-18 | EA - Each | 0597-0159 | a4f5f719-1233-44d2-8356-29051f08bfd0 | 1 | 2015-10-02 |
| 0597-0159-60 | EA - Each | 0597-0159 | c6a8da1d-5e57-45f3-a641-4ed42f47f29e | 1 | 2015-10-02 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| EMPAGLIFLOZIN | ACTIVE INGREDIENT | HDC1R2M35U | SYNJARDY (EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE) TABLET [BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.] | 1 | |
| METFORMIN HYDROCHLORIDE | ACTIVE INGREDIENT | 786Z46389E | SYNJARDY (EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE) TABLET [BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.] | 1 | |
| EMPAGLIFLOZIN | ACTIVE MOIETY | HDC1R2M35U | SYNJARDY (EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE) TABLET [BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.] | 1 | |
| METFORMIN | ACTIVE MOIETY | 9100L32L2N | SYNJARDY (EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE) TABLET [BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.] | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1665367 | empagliflozin 12.5 MG / metFORMIN HCl 1000 MG Oral Tablet | PSN | 0fdd0255-0055-65f3-b2c0-db8fbb87beae | 22 |
| 1664323 | empagliflozin 12.5 MG / metFORMIN HCl 500 MG Oral Tablet | PSN | 0fdd0255-0055-65f3-b2c0-db8fbb87beae | 22 |
| 1664326 | empagliflozin 5 MG / metFORMIN HCl 1000 MG Oral Tablet | PSN | 0fdd0255-0055-65f3-b2c0-db8fbb87beae | 22 |
| 1664315 | empagliflozin 5 MG / metFORMIN HCl 500 MG Oral Tablet | PSN | 0fdd0255-0055-65f3-b2c0-db8fbb87beae | 22 |
| 1665369 | Synjardy 12.5 MG / 1000 MG Oral Tablet | PSN | 0fdd0255-0055-65f3-b2c0-db8fbb87beae | 22 |
| 1664325 | Synjardy 12.5 MG / 500 MG Oral Tablet | PSN | 0fdd0255-0055-65f3-b2c0-db8fbb87beae | 22 |
| 1664328 | Synjardy 5 MG / 1000 MG Oral Tablet | PSN | 0fdd0255-0055-65f3-b2c0-db8fbb87beae | 22 |
| 1664321 | Synjardy 5 MG / 500 MG Oral Tablet | PSN | 0fdd0255-0055-65f3-b2c0-db8fbb87beae | 22 |
| 1665369 | empagliflozin 12.5 MG / metformin hydrochloride 1000 MG Oral Tablet [Synjardy] | SBD | 0fdd0255-0055-65f3-b2c0-db8fbb87beae | 22 |
| 1664325 | empagliflozin 12.5 MG / metformin hydrochloride 500 MG Oral Tablet [Synjardy] | SBD | 0fdd0255-0055-65f3-b2c0-db8fbb87beae | 22 |
| 1664328 | empagliflozin 5 MG / metformin hydrochloride 1000 MG Oral Tablet [Synjardy] | SBD | 0fdd0255-0055-65f3-b2c0-db8fbb87beae | 22 |
| 1664321 | empagliflozin 5 MG / metformin hydrochloride 500 MG Oral Tablet [Synjardy] | SBD | 0fdd0255-0055-65f3-b2c0-db8fbb87beae | 22 |
| 1665367 | empagliflozin 12.5 MG / metformin hydrochloride 1000 MG Oral Tablet | SCD | 0fdd0255-0055-65f3-b2c0-db8fbb87beae | 22 |
| 1664323 | empagliflozin 12.5 MG / metformin hydrochloride 500 MG Oral Tablet | SCD | 0fdd0255-0055-65f3-b2c0-db8fbb87beae | 22 |
| 1664326 | empagliflozin 5 MG / metformin hydrochloride 1000 MG Oral Tablet | SCD | 0fdd0255-0055-65f3-b2c0-db8fbb87beae | 22 |
| 1664315 | empagliflozin 5 MG / metformin hydrochloride 500 MG Oral Tablet | SCD | 0fdd0255-0055-65f3-b2c0-db8fbb87beae | 22 |
| 1665369 | Synjardy (empagliflozin 12.5 MG / metformin hydrochloride 1000 MG) Oral Tablet | SY | 0fdd0255-0055-65f3-b2c0-db8fbb87beae | 22 |
| 1664325 | Synjardy (empagliflozin 12.5 MG / metformin hydrochloride 500 MG) Oral Tablet | SY | 0fdd0255-0055-65f3-b2c0-db8fbb87beae | 22 |
| 1664328 | Synjardy (empagliflozin 5 MG / metformin hydrochloride 1000 MG) Oral Tablet | SY | 0fdd0255-0055-65f3-b2c0-db8fbb87beae | 22 |
| 1664321 | Synjardy (empagliflozin 5 MG / metformin hydrochloride 500 MG) Oral Tablet | SY | 0fdd0255-0055-65f3-b2c0-db8fbb87beae | 22 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 0597-0159-66 | 00597015966 | 1 BOTTLE in 1 CARTON (0597-0159-66) > 14 TABLET in 1 BOTTLE | 1 bottle | 2015-09-12 | 0000-00-00 | No | No | Current |